Hematopoietic growth factors (GFs) and transfused marrow or peripheral blood stem cells provide temporary hemotoxicity palliation. The mobilization of these cells may be prompted by chemotherapy alone or with various cytokines, such as the granulocyte and granulocyte-macrophagie colony-stimulating factor...
Until now, research on multiple myeloma cancer cells has often considered them as isolated entities. However, this tends to disregard the fact that the bone marrow environment, in particular the stromal bone tissue, the immune cells and the connective tissue cells, protects cancer cells with the ...
The evaluation of bone marrow of patients treated for cancer is complicated by age-related changes in the distribution of normal (red) and fatty (yellow) marrow and by the changes induced by treatments. The treatments used in oncology modify pathological marrow but also normal marrow and may som...
Hi, I suffer from cancer, and I am already having too much chemotherapy. I have to do a bone marrow transplant, because it will make me stronger and able to have more chemotherapy. I need to know some main things about this procedure. Remove Ads carie574 over a year ago Hi, I ...
当当中国进口图书旗舰店在线销售正版《【预订】Bone Marrow Transplants: A Guide for Cancer Patients》。最新《【预订】Bone Marrow Transplants: A Guide for Cancer Patients》简介、书评、试读、价格、图片等相关信息,尽在DangDang.com,网购《【预订】Bone Marrow Tr
University of Leipzig Medical Center and the Fraunhofer Institute for Cell Therapy and Immunology identified several biomarkers that are associated with the response to CAR T cell therapy in multiple myeloma, a malignant tumor disease in the bone marrow. Thefindingshave been published inNature Cancer....
Over the past decade, a greatly increased number of patients with advanced- stage hematologic and solid tumors have been treated with high-dose therapy and autologous bone marrow transplantation (ABMT) [1鈥 10]. There are several potentia... JG Gribben,LM Nadler - 《Cancer Treatment & Research...
P1–025RESEARCH ON THE SHIFT OF BONE-MARROW-SUPPRESSION AND THE USE OF G-CSF DUE TO FEC100 TREATMENT FOR BREAST CANCER. Nakamura,K.,Onikubo,... - 《Annals of Oncology》 被引量: 0发表: 2013年 [Bone marrow suppression--including guidelines for the appropriate use of G-CSF] For ...
Objective: The aim of this study was to compare bone marrow-sparing intensity-modulated radiotherapy (IMRT) with IMRT without entering pelvic bone marrow as a planning constraint in the treatment of cervical cancer after hysterectomy. Methods: For a cohort of 10 patients, bone marrow-sparing IMRT...
The Journal of Pathology and BacteriologySnow H (1898). The bone marrow of cancer patients: a reply to Dr Francis Villy's first paper. J Path Bact 5: 352–357.Villy F (1898). The bone marrow of cancer patients. J Path Bact 5: 69–67....